NATALIE NICHOLS: Open Payments
NPI 1821745373 · VENTURA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$709 in 30 payments from 13 companies in 2025. Trend: 2023 $383 · 2024 $201 · 2025 $709
Food & beverage: $709
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $123 |
| Amgen Inc. | 4 | $93 |
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| Radius Health, Inc. | 3 | $76 |
| Lilly USA, LLC | 3 | $71 |
| Gilead Sciences, Inc. | 2 | $62 |
| Dexcom, Inc. | 2 | $62 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| Ascensia Diabetes Care Us Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
Products named: FREESTYLE LIBRE 3, AIRSUPRA, Tymlos, MOUNJARO, Dexcom G6 Transmitter, EVENITY, TEPEZZA, TRELEGY ELLIPTA.
Industry payments across CA — which companies pay providers there.
